A Narrative Review of Acthar Gel for the Treatment of Myositis
Abstract Idiopathic inflammatory myopathies (IIMs) are autoimmune disorders characterized by symmetric proximal muscle weakness and chronic inflammation, with an increased risk of morbidity and mortality. The current standard of care includes traditional immunosuppressive pharmacotherapies; however,...
Main Authors: | Tanya Chandra, Rohit Aggarwal |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2023-03-01
|
Series: | Rheumatology and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s40744-023-00545-1 |
Similar Items
-
Results From a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis
by: Mehdi Mirsaeidi, et al.
Published: (2023-04-01) -
Clinical assessment of the potential use of a novel single-dose prefilled injection device for the administration of Acthar Gel in children: a narrative review
by: Johanna Purcell, et al.
Published: (2024-01-01) -
Cost-Effectiveness of Acthar Gel versus Standard of Care for the Treatment of Advanced Symptomatic Sarcoidosis
by: Bindra J, et al.
Published: (2023-10-01) -
Acthar Gel (RCI): A Narrative Literature Review of Clinical and Economic Evidence
by: Wan GJ, et al.
Published: (2023-06-01) -
Treatment of Noninfectious Retinal Vasculitis Using Subcutaneous Repository Corticotropin Injection
by: Stephen D. Anesi, et al.
Published: (2021-05-01)